Cardiol Therapeutics Inc. (TSX: CRDL)
Canada
· Delayed Price · Currency is CAD 1.870
-0.020 (-1.06%)
Dec 20, 2024, 4:00 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 152.60 million as of December 20, 2024. Its market cap has increased by 80.56% in one year.
Market Cap
152.60M
Enterprise Value
136.88M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.87
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 152.60M, an increase of 61.80%. That is a compound annual growth rate of 8.34%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch + Lomb Corporation | 9.07B |
| Bausch Health Companies Inc. | 3.90B |
| WELL Health Technologies Corp. | 1.75B |
| dentalcorp Holdings Ltd. | 1.60B |
| Curaleaf Holdings, Inc. | 1.58B |
| Tilray Brands, Inc. | 1.50B |
| Sienna Senior Living Inc. | 1.29B |
| Cronos Group Inc. | 1.04B |